Issuers of listed transferable securities are, following the Securities Trading Act section §5-11, required to provide Oslo Stock Exchange with an annual statement of information made available to the public the last 12 months following legal requirements.
Please find attached an overview for Hofseth BioCare ASA for the period 27 October 2011 to 19 June 2012. Hofseth BioCare has been required to publicly disclose inside information since the company applied for listing on 27 October 2011. The company was listed on Oslo Axess on 2 December 2011.
For more information, please contact:
Magne Aarsnes, CFO Hofseth BioCare ASATel: +47 900 12 212
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
